NeoGenomics Inc. Common Stock vs Northern Trust Corporation Common Stock — how do they compare? NeoGenomics Inc. Common Stock trades at $17.17 (market cap $2.14B), while Northern Trust Corporation Common Stock trades at $162.48 (market cap $30.63B). The key difference: Northern Trust Corporation Common Stock is far larger — about 14.3× NeoGenomics Inc. Common Stock's market cap, and Northern Trust Corporation Common Stock pays a 1.96% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and Northern Trust Corporation Common Stock for 0 Days on average.
| NEO | NTRS | |
|---|---|---|
Market Cap | $2.14B | $30.63B |
Volume | 2,228,400 | 964,550 |
Sector | Health | Financials |
52-Week High | $19.91 | $191.47 |
52-Week Low | $7.19 | $122.72 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $2.44B | -$5.35B |
Dividend Yield | — | 1.96% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →Northern Trust Corporation is a financial holding company that provides asset servicing, asset management, wealth management, and banking services through its Asset Servicing and Wealth Management segments. It serves corporations, institutions, and affluent individuals across US and international markets.
Read more on NTRS →